Clinical Trial: Corrected VA With Long-Term Follow-Up After AcrySof® Intraocular Lens (IOL) Implantation
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Corrected VA With Long-Term Follow-Up After AcrySof® IOL Implantation
Brief Summary: The purpose of this study is to compare the long-term visual acuity (VA) with an acrylic IOL to a silicone or polymethylmethacrylate (PMMA) IOL in cataract patients. This study will take place in Japan.
Detailed Summary:
Sponsor: Alcon, a Novartis Company
Current Primary Outcome: Mean Change From Baseline in Best Corrected Visual Acuity (BCVA) at the Long-Term, Post-Implantation Visit [ Time Frame: Baseline (up to and including 3 months after implantation), long-term post-implantation visit (14-20 years after implantation) ]
Original Primary Outcome: Change From Baseline in Best Corrected Visual Acuity (BCVA) at the Long-Term, Post-Implantation Visit [ Time Frame: Baseline (up to and including 3 months after implantation), long-term post-implantation visit (14-20 years after implantation) ]
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Alcon Research
Dates:
Date Received: May 19, 2015
Date Started: June 2015
Date Completion:
Last Updated: October 17, 2016
Last Verified: October 2016